Related Experiment Video
Updated: Jun 27, 2026

05:49
Modeling the Effects of Hemodynamic Stress on Circulating Tumor Cells using a Syringe and Needle
Published on: April 27, 2021
Intratumoral B cells under stress
1Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
Cancer Cell
|June 25, 2026
Summary
Stress hormone corticosterone hinders anti-tumor immunity by suppressing B cell responses. Gut bacteria-derived phage DNA activates immune cells, leading to corticosterone release and impaired cancer immunity.
Area of Science:
- Immunology
- Cancer Biology
- Microbiome Research
Background:
- Stress hormones like corticosterone can impact immune function.
- Germinal center B cell responses are crucial for effective anti-tumor immunity.
- The interplay between gut microbiota and cancer-associated fibroblasts (CAFs) in immune suppression is not fully understood.
Purpose of the Study:
- To investigate how stress-induced corticosterone affects germinal center B cell responses and anti-tumor immunity.
- To identify the specific triggers and mechanisms by which corticosterone is secreted in the tumor microenvironment.
- To elucidate the role of gut microbiota in activating immune-suppressive pathways.
Main Methods:
- Analysis of B cell responses in the presence of corticosterone.
- Investigating Toll-like receptor 9 (TLR9) activation by microbial DNA.
- Assessing corticosterone secretion by cancer-associated fibroblasts (CAFs).
- Utilizing mouse models to study gut microbiota-derived signals.
Main Results:
- Stress-induced corticosterone was found to suppress germinal center B cell responses.
- Impaired anti-tumor immunity was observed due to corticosterone.
- Gut microbiota-derived phage DNA was identified as a trigger for TLR9 activation.
- CAFs were shown to secrete corticosterone upon TLR9 activation.
Conclusions:
- Stress significantly impairs anti-tumor immunity by suppressing B cell responses via corticosterone.
- Gut microbiota-derived phage DNA is a critical factor initiating TLR9 activation and subsequent corticosterone release from CAFs.
- This study reveals a novel bacteria-driven mechanism of immune suppression in cancer.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

